ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Hyperglycemia"

  • 2022 American Transplant Congress

    Sodium-Glucose Co-Transporter 2 Inhibitors; Short-Term Outcome in Diabetic Kidney Transplant Recipients

    J. Yagan1, T. S. Mahmoud1, A. Hasan2, O. Gheith1, n. El-Serwy1, S. Rida1, M. Mostafa1, M. Shaker1, P. Nair1, T. Alotaibi1

    1Nephrology, Hamed Al-Essa Organ Transplant Center, Kuwait, Kuwait, 2Immunometabolism, Dasman Diabetes Center, Kuwait, Kuwait

    *Purpose: The idea of using SGLT2i in kidney transplant recipients (KTR) is a legitimate one after the recent encouraging data for their use in other…
  • 2022 American Transplant Congress

    Outcomes of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Diabetic Kidney Transplant Recipients

    T. S. Mahmoud1, J. Yagan1, A. Hasan2, O. Gheith1, M. Mostafa1, S. Rida1, N. El-Serwy1, M. Shaker1, M. Khalid1, P. Nair1, T. Alotaibi1

    1Nephrology, Organ Transplant Center, Kuwait, Kuwait, 2Immunometabolism, Dasman Diabetes Center, Kuwait, Kuwait

    *Purpose: The impact of the new glucose lowering therapies, sodium-glucose cotransporter 2 inhibitors (SGLT2i) and Glucagon-like peptide-1 receptor agonists (GLP-1RA), on managing patients with type…
  • 2022 American Transplant Congress

    Safety and Efficacy of GLP-1 Agonists in Solid Organ Transplant Recipients

    E. Heiman, D. Blanco, A. Webb

    Pharmacy, Tampa General Hospital, Tampa, FL

    *Purpose: Glucagon-like peptide-1 receptor agonists (GLP-1 RA) have been shown to improve glycemic control, obesity, and cardiovascular disease in the general population. The safety and…
  • 2022 American Transplant Congress

    Impact of a Pharmacy-Led Post-Transplant Diabetes Mellitus Clinic in Solid Organ Transplant Recipients

    H. Sweiss1, R. Hall1, M. Flores2, S. Bhayana1, R. Patel1, C. Long2

    1University Health - University Hospital, San Antonio, TX, 2College of Pharmacy, University of Incarnate Word, San Antonio, TX

    *Purpose: To evaluate the impact of a pharmacy-led post-transplant diabetes mellitus (DM) clinic.*Methods: This retrospective chart review from 08/01/20 to 6/30/21 evaluated adult kidney transplant…
  • 2022 American Transplant Congress

    Everolimus versus Mycophenolate in Simultaneous Pancreas and Kidney Transplantation: Progression of Diabetic Retinopathy in a Prospective Randomized Trial

    B. Hagerf1, Z. Hladíková1, M. Zahradnická1, K. Kesslerová2, T. Sosna2, P. Girman1, F. Saudek1

    1Diabetes Centre, IKEM, Prague, Czech Republic, 2Ophtalmology Clinic, Thomayer Hospital, Prague, Czech Republic

    *Purpose: mTOR inhibitors are known for their antiangiogenic effect. We compared the impact of everolimus (E) and mycophenolic acid (MPA) on the course of diabetic…
  • 2022 American Transplant Congress

    Evaluation of GLP-1 Receptor Agonist Use in the Solid Organ Transplant Population

    S. E. Lawrence, M. R. Norvell, K. Schwarz, B. Crowther, P. Klem

    Pharmacy, University of Colorado Hospital, Aurora, CO

    *Purpose: The purpose of this study was to evaluate the utilization of and identify opportunities to optimize the use of glucagon-like peptide-1 receptor agonist (GLP-1…
  • 2022 American Transplant Congress

    Engineered Adaptable Human Endothelial Cells Enable Durable Engraftment of Subcutaneously Transplanted Islets

    R. Craig-Schapiro, G. Li, S. Rafii

    Weill Cornell Medical College, New York, NY

    *Purpose: The current clinical practice of islet transplantation into the portal vein is suboptimal, with reduced vascularization limiting successful engraftment and the inability for monitoring…
  • 2022 American Transplant Congress

    Safety and Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Solid Organ Transplant

    H. Sweiss1, D. Zeilmann1, J. Escamilla2, R. Hall1, S. Bhayana1, R. Patel1, C. Long2

    1University Health - University Hospital, San Antonio, TX, 2College of Pharmacy, University of Incarnate Word, San Antonio, TX

    *Purpose: To evaluate the safety and efficacy of glucagon-like peptide-1 receptor agonists (GLP1-RA) in solid organ transplant (SOT).*Methods: This retrospective review included adult kidney, liver,…
  • 2022 American Transplant Congress

    Sodium-Glucose Cotransporter 2 Inhibitors to Treat Diabetes Mellitus After Kidney Transplant

    H. M. Brokmeier1, S. B. Leung1, A. Kukla2, K. C. Mara3, P. Shah4, Y. Kudva4, G. K. Mour5, H. M. Wadei6, J. M. Hill7, M. D. Stegall8, A. Lemke1

    1Pharmacy, Mayo Clinic, Rochester, MN, 2Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, 3Health Sciences Research, Mayo Clinic, Rochester, MN, 4Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, MN, 5Nephrology Transplant, Mayo Clinic, Phoenix, AZ, 6Nephrology, Mayo Clinic, Jacksonville, FL, 7Transplant, Mayo Clinic, Rochester, MN, 8Division of Transplant Surgery, Mayo Clinic, Rochester, MN

    *Purpose: This study describes experience prescribing sodium-glucose cotransport 2 inhibitors (SGLT2i) after kidney transplant to evaluate safety and effectiveness.*Methods: This is a retrospective, institutional review…
  • 2022 American Transplant Congress

    Assessment of Insulin Utilization for Early Post-Transplant Glycemic Control in Liver Transplant

    L. F. Borges, K. Gutierrez, T. A. Sparkman, J. Banbury

    UAB Hospital, Birmingham, AL

    *Purpose: Transient hyperglycemia after liver transplant (LT) is common due to the use of high-dose steroids at the time of transplant, but some patients may…
  • 1
  • 2
  • 3
  • …
  • 7
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences